Showing results (521-530 of 649) with videos related to
Sort By:
Pageof 65
Journal of the Advanced Practitioner in Oncology|February 6, 2019
Clinical Management of Pneumonitis in Patients Receiving Anti-PD-1/PD-L1 TherapyJustin E Bala-Hampton, Angela F Bazzell, Joyce E DainsJournal of the Advanced Practitioner in Oncology|February 6, 2019
Enasidenib: An Oral IDH2 Inhibitor for the Treatment of Acute Myeloid LeukemiaRebecca A Myers, Scott Wirth, Sherry Williams, et al.Journal of the Advanced Practitioner in Oncology|December 28, 2018
Acute Promyelocytic Leukemia: A SummaryMeaghan M RyanJournal of the Advanced Practitioner in Oncology|December 28, 2018
Drug-Drug Interactions, Safety, and Pharmacokinetics of EGFR Tyrosine Kinase Inhibitors for the Treatment of Non-Small Cell Lung CancerColleen R Kucharczuk, Alex Ganetsky, J Michael VozniakJournal of the Advanced Practitioner in Oncology|October 3, 2025
Understanding the Role and Clinical Management of Bridging Therapy During CAR T-Cell Therapy for Relapsed or Refractory Multiple MyelomaYi L Hwa, Deborah Doss, Patricia A Mangan, et al.Journal of the Advanced Practitioner in Oncology|July 2, 2025
Persistent Poverty, Rural Location, and Racial Segregation Are Factors in Colorectal Cancer Screening in Low-Income and Uninsured PopulationsWen Hsin Chen, Rosaleen D Bloom, Arica Brandford, et al.Journal of the Advanced Practitioner in Oncology|December 5, 2025
Advanced Practice Provider-Led Trials in Radiation Oncology: Are We Missing the Opportunity?Molly K TateJournal of the Advanced Practitioner in Oncology|December 5, 2025
Long-Term Safety and Management of Adverse Events Associated With Lorlatinib in ALK-Positive Metastatic NSCLC: A Fictional Case StudyElizabeth A Krueger, Elizabeth Castronovo, Eunah Cho, et al.Journal of the Advanced Practitioner in Oncology|July 18, 2014
Neurotoxicity associated with cancer therapyEva Lu Lee, Laurel WestcarthJournal of the Advanced Practitioner in Oncology|July 18, 2014
Vaccination recommendations for the hematology and oncology and post-stem cell transplant populationsVivian TsangPageof 65